Coridon
Coridon develops DNA therapies for the prevention and treatment of viral infections, and therapeutic vaccines for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€11—16m (Dealroom.co estimates Jul 2010.)
Brand Vorarlberg (HQ)
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.